CJS Securities initiated coverage of WW with a rating of Market Perform
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/15/2025 | Market Perform | CJS Securities | |
| 7/26/2024 | $6.50 → $1.25 | Overweight → Equal-Weight | Morgan Stanley |
| 1/3/2024 | $8.00 | Underweight | Barclays |
| 12/20/2023 | $14.00 | Buy | Guggenheim |
| 9/27/2023 | $4.00 → $10.00 | Sell → Hold | Craig Hallum |
| 7/26/2023 | $5.00 → $13.00 | Equal-Weight → Overweight | Morgan Stanley |
| 4/11/2023 | $3.80 → $13.00 | Neutral → Buy | Goldman |
| 3/8/2023 | $4.00 | Hold → Sell | Craig Hallum |
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers" or the "Company"), the global leader in science-backed weight management, today announced that the Company will be participating in the following investor conferences in January: January 12-13, 2026: ICR Conference in Orlando, FL. The Company will host meetings with investors throughout the event.January 14, 2026: CJS Securities 26th Annual New Ideas for the New Year. The Company will be participating in a virtual fireside chat at 11:00 a.m. ET. The fireside chat will be accessible via live audio webcast on the Company's corporate website, corporate.ww.com, under Events and Presentations. A r
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced access to Novo Nordisk's newly FDA approved oral formulation of Wegovy® through its integrated GLP-1 platform. The addition of a once-daily Wegovy pill expands access to GLP-1 treatment and reinforces Weight Watchers' leadership in delivering comprehensive care models that help people succeed on medication in real life by pairing medical therapy with evidence-based behavior change and ongoing support. Weight Watchers, through its affiliated Weight Watchers Clinic, is a NovoCare® Recognized Care Provider based on its demonstr
NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight management, today introduced a new, fully integrated experience bringing together comprehensive support for members on GLP-1 medications, personalized nutrition, behavioural support, coaching, and community within a redesigned app and digital platform. Built for a new era of weight management and long-term health, the new integrated offering delivers coordinated, evidence-based support that adapts to members' lives and helps them achieve—and sustain—superior results. "As GLP-1 medications become available in more markets, people are increasingly lo
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
S-8 POS - WW INTERNATIONAL, INC. (0000105319) (Filer)
S-8 POS - WW INTERNATIONAL, INC. (0000105319) (Filer)
CJS Securities initiated coverage of WW with a rating of Market Perform
Morgan Stanley downgraded WW from Overweight to Equal-Weight and set a new price target of $1.25 from $6.50 previously
Barclays initiated coverage of WW with a rating of Underweight and set a new price target of $8.00
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") will release its results for the third quarter 2025 ended September 30, 2025, before market open on Thursday, November 6, 2025. WeightWatchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days. About WeightWatchersWeightWatchers is the global leader in science-backed weight management, offering an integrated support system that co
Successful completion of strategic reorganization, reducing debt by $1.15 billion.In connection with emergence on 6/24/25, fiscal Q2 consists of a "Predecessor" period from 3/30/25 to 6/24/25, and a "Successor" period from 6/25/25 to 6/30/25 Combined End of Period Subscribers1 of 3.2 million; Combined End of Period Clinical Subscribers1 of 127 thousand Combined Revenues1 of $189 million, down 6% vs. prior year; Combined Clinical Revenues1 of $31 million, up 55% vs. prior year Predecessor Net Income1 of $1,191 million and Net Margin1 of 673% were impacted by Reorganization items; Successor Net Income1 of $1 million and Net Margin1 of 10%; Predecessor Adjusted EBITDA1,2 of $61 milli
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") reschedules its earnings release and conference call for the quarterly period ended June 30, 2025, to finalize its Fresh Start Accounting adoption in connection with the emergence from its financial reorganization process on June 24, 2025. The earnings release and call was originally scheduled before the market opened on Tuesday, August 5, 2025. WeightWatchers will now release its second quarter 2025 earnings release before market open on Monday, August 11, 2025, and host a conference call to discuss results the same day at 8:30 a.m. ET. The webcast of the conference c
SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)
SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)
SC 13G - WW INTERNATIONAL, INC. (0000105319) (Subject)
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking programme that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the programme, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman. "Menopause has been a new journey for me—one that's changed how I see a
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the launch of WeightWatchers for Menopause, a groundbreaking program that sets a new standard in women's health, designed to support women through every stage of the menopause journey, from perimenopause to post-menopause. To launch the program, WeightWatchers is partnering with Grammy and Emmy Award-winning and Oscar-nominated actress, producer, entrepreneur, and health advocate Queen Latifah as its first official spokeswoman "Menopause has been a new journey for me—one that's changed how I s
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers" or the "Company"), the global leader in science-backed weight management, today announced the appointment of Alejandro Bethlen as Executive Vice President, International, effective immediately. In this role, Bethlen will oversee WeightWatchers' business outside of the United States, driving international growth and innovation across the Company's global footprint. With more than two decades of experience scaling consumer, e-commerce, and marketplace businesses worldwide, Bethlen will play a pivotal role in strengthening WeightWatchers' leadership in weight health. "Alejandro's international e